can tirzepatide cause hives Severe reaction to injection What are the management options

This work was supported by the Robert Bosch Foundation, Stuttgart, Germany, Deutsche Forschungsgemeinschaft (DFG, SCHR 1323/2-1 and MU 1727/2-1), Germany and IZEPHA (Grant 21-0-0), Germany, The German Cancer Consortium (DKTK), American University of Beirut Medical Practice Plan (AUBMPP), and National Medical Research Council Grant NMRC/1159/2008 and NMRCG13161

GLP-1 Clinical Practice Updates: September 2025 Key Developments September 2025 brought several notable developments in the GLP-1 and weight management space, including new clinical trial data, regulatory guidance changes, and policy updates from the WHO

GLP-1 in higher amounts also interacts with the parts of the brain that reduce appetite and signals a feeling of fullness

In addition to socioeconomic and demographic information, data collected included weight, height and body mass index (BMI)